Evaluating the effect of manipulating some of the dysregulated metabolites on breast cancer cell proliferation, migration and invasion in the context of fascin expression would strengthen the link between fascin-mediated dysregulation of these metabolites and the observed functions. This evidence concerns the gene FSCN1 and breast cancer.